INNOVATE Corp VATE 深 沪
等待开盘 04-03 09:30:00 美东时间
7.77
+0.940
+13.76%
华盛通- 最 高8.10
- 今 开6.80
- 成交量 10.20万股
- 最 低 6.56
- 昨 收 6.83
- 总市值 1.06亿
- 52周最高 8.28
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 3.75
- 委 比 -75.44%
- 总股本 1364.51万
- 历史最高 170.1074
- 量 比 1.42
- 振 幅 22.55%
- 历史最低 3.75
- 每 手 1
- 风险率 0.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
INNOVATE Corp.'s portfolio company, MediBeacon Inc., has received EU CE Mark certification for its TGFR™ Monitor and Reusable Sensor under the EU Medical Device Regulation (MDR). This certification validates the devices' safety, quality, and performance. The TGFR System, which includes the certified Monitor and Sensor, along with Lumitrace® injection and Disposable Ring, measures kidney function via transdermal detection of fluorescent agents. Lu...
03-31 12:05
12 Industrials Stocks Moving In Friday's Intraday Session
Gainers Globavend Holdings (NASDAQ:GVH) shares increased by 36.0% to $1.4 duri...
03-28 01:05
Innovate Q4 EPS $(0.58) Up From $(1.29) YoY, Sales $382.700M Up From $236.600M YoY
Innovate (NYSE:VATE) reported quarterly losses of $(0.58) per share. This is a 55.04 percent increase over losses of $(1.29) per share from the same period last year. The company reported $382.700 million in sales this
03-27 04:06
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
INNOVATE Corp. (NYSE: VATE) announced it will release its 4Q and full-year 2025 financial results on March 26, 2026, after market close. A conference call reviewing the results, operations, and strategy will be held the same day at 4:30 p.m. ET. The call can be accessed via dial-in numbers or live webcast on INNOVATE’s Investor Relations website. A replay will be available shortly after the call and accessible through April 9, 2026. INNOVATE is a...
03-16 20:05
Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)
<p>NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. announced that MediBeacon Inc., a medical technology company it owns a 44.7% stake in, has been recognized by the Journal of the American Society of Nephrology (JASN) for its transdermal GFR measurement system. The TGFR™ System, which includes Lumitrace® injection, the TGFR™ Monitor, and a reusable sensor, enables non-invasive assessment of kidney function by measuring the clearance ra...
02-10 21:05
INNOVATE Corp Subsidiary DBM Global Declares Cash Dividend
An update from INNOVATE Corp ( ($VATE) ) is now available. On February 2, 2026,...
02-02 21:59
INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend
<p>INNOVATE Corp. announced that its subsidiary, DBM Global Inc. (DBMG), will pay a cash dividend of approximately $5 million ($1.30 per share) on February 24, 2026, to stockholders of record as of February 9, 2026. INNOVATE, as DBMG’s largest stockholder, expects to receive approximately $4.6 million of the total payout. The dividend is not available to INNOVATE’s individual stockholders. DBMG provides integrated steel construction services and ...
02-02 13:30
Innovate Q3 EPS $(0.71) Up From $(1.18) YoY, Sales $347.100M Up From $242.200M YoY
Innovate (NYSE:VATE) reported quarterly losses of $(0.71) per share. This is a 39.83 percent increase over losses of $(1.18) per share from the same period last year. The company reported $347.100 million in sales this
2025-11-13 05:04
BRIEF-INNOVATE Corp. Q3 Revenue USD 347.1 Million
Nov 12 (Reuters) - INNOVATE Corp. Q3 net income USD -9.4 million. Q3 adjusted EBITDA USD 19.8 million Q3 EPS USD -0.71
2025-11-13 05:04
